Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.

Solaris Endovascular, Inc. announced that the DEScover clinical trial has completed enrollment. According to the comp ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...

Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings ...

FAIRWAY, Kan.--(BUSINESS WIRE)--Flow Forward Medical Inc. (Flow Forward), a medical device company focused on improving outcomes for hemodialysis patients through the rapid creation of high-quality ...

Please provide your email address to receive an email when new articles are posted on . According to recently published results, insurance-related disparities in the use of arteriovenous fistulas and ...

The study findings might indicate residual kidney function preservation in advanced CKD. Arteriovenous fistula (AVF) creation is associated with a slowing of kidney function decline in patients with ...

This requires durable access to a blood vessel site where the dialysis machine can remove and return blood. Such access is created when a surgeon attaches a vein to an artery in the patient. The ...